Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.93896762 |
2 | L-phenylalanine catabolic process (GO:0006559) | 5.93896762 |
3 | L-phenylalanine metabolic process (GO:0006558) | 5.90123999 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.90123999 |
5 | lysine catabolic process (GO:0006554) | 5.52434938 |
6 | lysine metabolic process (GO:0006553) | 5.52434938 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 5.29733376 |
8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.29124442 |
9 | glyoxylate metabolic process (GO:0046487) | 5.28822450 |
10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.26975829 |
11 | * fatty acid beta-oxidation (GO:0006635) | 5.17246503 |
12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.07334414 |
13 | regulation of sequestering of triglyceride (GO:0010889) | 4.99474798 |
14 | regulation of triglyceride catabolic process (GO:0010896) | 4.90492948 |
15 | kynurenine metabolic process (GO:0070189) | 4.82536198 |
16 | amino-acid betaine metabolic process (GO:0006577) | 4.82502326 |
17 | * fatty acid oxidation (GO:0019395) | 4.76696617 |
18 | indolalkylamine catabolic process (GO:0046218) | 4.75821958 |
19 | tryptophan catabolic process (GO:0006569) | 4.75821958 |
20 | indole-containing compound catabolic process (GO:0042436) | 4.75821958 |
21 | fatty acid transmembrane transport (GO:1902001) | 4.74227618 |
22 | cysteine metabolic process (GO:0006534) | 4.71263762 |
23 | * lipid oxidation (GO:0034440) | 4.68400968 |
24 | * fatty acid catabolic process (GO:0009062) | 4.66427464 |
25 | bile acid biosynthetic process (GO:0006699) | 4.64936325 |
26 | exogenous drug catabolic process (GO:0042738) | 4.61941278 |
27 | sulfur amino acid catabolic process (GO:0000098) | 4.61329098 |
28 | short-chain fatty acid metabolic process (GO:0046459) | 4.59720553 |
29 | acetyl-CoA metabolic process (GO:0006084) | 4.59208567 |
30 | valine metabolic process (GO:0006573) | 4.57833181 |
31 | carnitine shuttle (GO:0006853) | 4.54591393 |
32 | cellular ketone body metabolic process (GO:0046950) | 4.52316905 |
33 | xenobiotic catabolic process (GO:0042178) | 4.52013745 |
34 | tryptophan metabolic process (GO:0006568) | 4.48923129 |
35 | branched-chain amino acid catabolic process (GO:0009083) | 4.48610606 |
36 | 2-oxoglutarate metabolic process (GO:0006103) | 4.47666550 |
37 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.40923476 |
38 | * monocarboxylic acid catabolic process (GO:0072329) | 4.33969673 |
39 | carnitine metabolic process (GO:0009437) | 4.32963990 |
40 | homocysteine metabolic process (GO:0050667) | 4.25667959 |
41 | serine family amino acid catabolic process (GO:0009071) | 4.23703766 |
42 | urea cycle (GO:0000050) | 4.23488542 |
43 | urea metabolic process (GO:0019627) | 4.23488542 |
44 | positive regulation of fatty acid oxidation (GO:0046321) | 4.21611115 |
45 | branched-chain amino acid metabolic process (GO:0009081) | 4.18662157 |
46 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.16756872 |
47 | aspartate family amino acid catabolic process (GO:0009068) | 4.15605540 |
48 | acylglycerol homeostasis (GO:0055090) | 4.13906451 |
49 | triglyceride homeostasis (GO:0070328) | 4.13906451 |
50 | complement activation, alternative pathway (GO:0006957) | 4.11192848 |
51 | tricarboxylic acid cycle (GO:0006099) | 4.10030816 |
52 | high-density lipoprotein particle remodeling (GO:0034375) | 4.08190823 |
53 | alpha-amino acid catabolic process (GO:1901606) | 4.07266493 |
54 | biotin metabolic process (GO:0006768) | 4.02561999 |
55 | regulation of fatty acid oxidation (GO:0046320) | 4.01926489 |
56 | ethanol oxidation (GO:0006069) | 4.01901577 |
57 | negative regulation of fibrinolysis (GO:0051918) | 3.96412390 |
58 | protein carboxylation (GO:0018214) | 3.96222190 |
59 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.96222190 |
60 | bile acid metabolic process (GO:0008206) | 3.95521143 |
61 | nitrogen cycle metabolic process (GO:0071941) | 3.95128574 |
62 | plasma lipoprotein particle clearance (GO:0034381) | 3.93406515 |
63 | aromatic amino acid family metabolic process (GO:0009072) | 3.93346841 |
64 | ketone body metabolic process (GO:1902224) | 3.91787779 |
65 | positive regulation of lipid catabolic process (GO:0050996) | 3.90320856 |
66 | * organic acid catabolic process (GO:0016054) | 3.89671479 |
67 | * carboxylic acid catabolic process (GO:0046395) | 3.89671479 |
68 | cellular amino acid catabolic process (GO:0009063) | 3.89367037 |
69 | regulation of protein activation cascade (GO:2000257) | 3.88838095 |
70 | glucuronate metabolic process (GO:0019585) | 3.86710018 |
71 | uronic acid metabolic process (GO:0006063) | 3.86710018 |
72 | coenzyme catabolic process (GO:0009109) | 3.81472019 |
73 | omega-hydroxylase P450 pathway (GO:0097267) | 3.76877743 |
74 | regulation of fibrinolysis (GO:0051917) | 3.75707118 |
75 | phenylpropanoid metabolic process (GO:0009698) | 3.73305807 |
76 | tyrosine metabolic process (GO:0006570) | 3.72418515 |
77 | protein-lipid complex remodeling (GO:0034368) | 3.72051005 |
78 | macromolecular complex remodeling (GO:0034367) | 3.72051005 |
79 | plasma lipoprotein particle remodeling (GO:0034369) | 3.72051005 |
80 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.70815436 |
81 | drug metabolic process (GO:0017144) | 3.67267816 |
82 | regulation of complement activation (GO:0030449) | 3.65839683 |
83 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.63732957 |
84 | carnitine transmembrane transport (GO:1902603) | 3.63334254 |
85 | tricarboxylic acid metabolic process (GO:0072350) | 3.63172432 |
86 | reverse cholesterol transport (GO:0043691) | 3.62416597 |
87 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.62101819 |
88 | respiratory electron transport chain (GO:0022904) | 3.61863759 |
89 | carnitine transport (GO:0015879) | 3.61727220 |
90 | amino-acid betaine transport (GO:0015838) | 3.61727220 |
91 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.60747757 |
92 | ATP synthesis coupled proton transport (GO:0015986) | 3.60747757 |
93 | regulation of cholesterol esterification (GO:0010872) | 3.58603722 |
94 | regulation of cholesterol metabolic process (GO:0090181) | 3.58283831 |
95 | negative regulation of lipase activity (GO:0060192) | 3.52230028 |
96 | electron transport chain (GO:0022900) | 3.52204417 |
97 | phospholipid homeostasis (GO:0055091) | 3.51137016 |
98 | cellular glucuronidation (GO:0052695) | 3.50702219 |
99 | NADH metabolic process (GO:0006734) | 3.50071807 |
100 | heart process (GO:0003015) | 3.49824283 |
101 | heart contraction (GO:0060047) | 3.49824283 |
102 | ethanol metabolic process (GO:0006067) | 3.49442835 |
103 | succinate metabolic process (GO:0006105) | 3.46899800 |
104 | cellular modified amino acid catabolic process (GO:0042219) | 3.45043840 |
105 | phospholipid efflux (GO:0033700) | 3.42815697 |
106 | glutamate metabolic process (GO:0006536) | 3.42639354 |
107 | serine family amino acid metabolic process (GO:0009069) | 3.42343911 |
108 | triglyceride catabolic process (GO:0019433) | 3.42090083 |
109 | acyl-CoA metabolic process (GO:0006637) | 3.41630679 |
110 | thioester metabolic process (GO:0035383) | 3.41630679 |
111 | epoxygenase P450 pathway (GO:0019373) | 3.38837073 |
112 | glycine metabolic process (GO:0006544) | 3.37864226 |
113 | drug catabolic process (GO:0042737) | 3.37132117 |
114 | benzene-containing compound metabolic process (GO:0042537) | 3.37071660 |
115 | S-adenosylmethionine metabolic process (GO:0046500) | 3.35687623 |
116 | negative regulation of sterol transport (GO:0032372) | 3.35449323 |
117 | negative regulation of cholesterol transport (GO:0032375) | 3.35449323 |
118 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.23408008 |
119 | polyketide metabolic process (GO:0030638) | 3.19098388 |
120 | doxorubicin metabolic process (GO:0044598) | 3.19098388 |
121 | daunorubicin metabolic process (GO:0044597) | 3.19098388 |
122 | fibrinolysis (GO:0042730) | 3.18838262 |
123 | blood coagulation, intrinsic pathway (GO:0007597) | 3.10942091 |
124 | arginine metabolic process (GO:0006525) | 3.06549544 |
125 | aldehyde catabolic process (GO:0046185) | 2.95014451 |
126 | oxidative demethylation (GO:0070989) | 2.94358064 |
127 | hormone catabolic process (GO:0042447) | 2.90059552 |
128 | actin-myosin filament sliding (GO:0033275) | 2.88834908 |
129 | muscle filament sliding (GO:0030049) | 2.88834908 |
130 | bile acid and bile salt transport (GO:0015721) | 2.88167018 |
131 | oxaloacetate metabolic process (GO:0006107) | 2.86488097 |
132 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.82076416 |
133 | negative regulation of protein activation cascade (GO:2000258) | 2.79256344 |
134 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.78135462 |
135 | oxidative phosphorylation (GO:0006119) | 2.77706048 |
136 | primary alcohol metabolic process (GO:0034308) | 2.77670810 |
137 | arginine catabolic process (GO:0006527) | 2.76059253 |
138 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.74878415 |
139 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.74878415 |
140 | primary alcohol catabolic process (GO:0034310) | 2.74404150 |
141 | phenol-containing compound catabolic process (GO:0019336) | 2.73583801 |
142 | alkaloid metabolic process (GO:0009820) | 2.71229953 |
143 | response to nitrosative stress (GO:0051409) | 2.66504282 |
144 | xenobiotic metabolic process (GO:0006805) | 2.66056322 |
145 | vitamin biosynthetic process (GO:0009110) | 2.65978304 |
146 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.64450059 |
147 | peroxisome fission (GO:0016559) | 2.63744164 |
148 | negative regulation of complement activation (GO:0045916) | 2.62343827 |
149 | negative regulation of blood coagulation (GO:0030195) | 2.60893880 |
150 | negative regulation of hemostasis (GO:1900047) | 2.60893880 |
151 | flavonoid metabolic process (GO:0009812) | 2.55593650 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.88463159 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.22453165 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.35225750 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.69407019 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.36541992 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.46053724 |
7 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.25974270 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.14809955 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.61989075 |
10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.51929140 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.99709977 |
12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.95398294 |
13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.47471496 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.42377765 |
15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.23253659 |
16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.12804961 |
17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11279746 |
18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.10479887 |
19 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.09601348 |
20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3378577 |
21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.99087999 |
22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.99021793 |
23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92422556 |
24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90681385 |
25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.82303516 |
26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.77001198 |
27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.71276385 |
28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.66383927 |
29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54108064 |
30 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.45613444 |
31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40832718 |
32 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.35631160 |
33 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30898372 |
34 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29470448 |
35 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28435278 |
36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28154965 |
37 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.27144896 |
38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.27119497 |
39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26486870 |
40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.25373367 |
41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25249354 |
42 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25161775 |
43 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.23969167 |
44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21283440 |
45 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.21184789 |
46 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.20908731 |
47 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.20308939 |
48 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.16015217 |
49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15669431 |
50 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15158025 |
51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15145900 |
52 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.14728828 |
53 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12363688 |
54 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12128537 |
55 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12128537 |
56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12076610 |
57 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.11892003 |
58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11703843 |
59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10823362 |
60 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.09212903 |
61 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.09212903 |
62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08923354 |
63 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.07020966 |
64 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.06276612 |
65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05132206 |
66 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.03817748 |
67 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03151085 |
68 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02541620 |
69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01728403 |
70 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01458035 |
71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01399179 |
72 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.99987140 |
73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99549018 |
74 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.98468833 |
75 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.98468833 |
76 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98398413 |
77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98184872 |
78 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97925144 |
79 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.97881739 |
80 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.97392934 |
81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95271771 |
82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95169632 |
83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95134068 |
84 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.94145230 |
85 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93911370 |
86 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.93630996 |
87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93014400 |
88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92959975 |
89 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92634695 |
90 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92609496 |
91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92467404 |
92 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.91549400 |
93 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.90291410 |
94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90046623 |
95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.89622753 |
96 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.89511088 |
97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88610366 |
98 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.88563524 |
99 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.86912849 |
100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86709998 |
101 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86691908 |
102 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86464029 |
103 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85431449 |
104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.84355876 |
105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.83974643 |
106 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.83157216 |
107 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.83040790 |
108 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.82897600 |
109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82683009 |
110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81082899 |
111 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79611858 |
112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78042961 |
113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76567829 |
114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76323433 |
115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76323433 |
116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75444038 |
117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73986336 |
118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72519776 |
119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70601415 |
120 | AR_20517297_ChIP-Seq_VCAP_Human | 0.66802226 |
121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66651466 |
122 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.66304648 |
123 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.63845050 |
124 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.62382309 |
125 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.61962206 |
126 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.61531779 |
127 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.60930581 |
128 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60670947 |
129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59793423 |
130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59422709 |
131 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.59272300 |
132 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.58040648 |
133 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.57141029 |
134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56375217 |
135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.55911627 |
136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.55683503 |
137 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.55042468 |
138 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.54855836 |
139 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.54769433 |
140 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.54604955 |
141 | CBP_21632823_ChIP-Seq_H3396_Human | 0.53301402 |
142 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.53031567 |
143 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53017743 |
144 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51917402 |
145 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.51767987 |
146 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50945819 |
147 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.50915816 |
148 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.50434181 |
149 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.48985710 |
150 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.48748550 |
151 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48631387 |
152 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48612465 |
153 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47832452 |
154 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.47660724 |
155 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46445126 |
156 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.45507698 |
157 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44761677 |
158 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.44496303 |
159 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.44439916 |
160 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44399263 |
161 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.44267567 |
162 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44013392 |
163 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.43734274 |
164 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.43643989 |
165 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.43349100 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.74944190 |
2 | MP0005360_urolithiasis | 6.18028555 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.22642657 |
4 | MP0005365_abnormal_bile_salt | 5.12772855 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.90396385 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.46038099 |
7 | MP0010329_abnormal_lipoprotein_level | 3.25600343 |
8 | MP0003252_abnormal_bile_duct | 3.18488629 |
9 | MP0005332_abnormal_amino_acid | 2.86518335 |
10 | MP0005670_abnormal_white_adipose | 2.85108001 |
11 | MP0004130_abnormal_muscle_cell | 2.66103866 |
12 | MP0003195_calcinosis | 2.65927631 |
13 | MP0002837_dystrophic_cardiac_calcinosis | 2.61129850 |
14 | MP0009840_abnormal_foam_cell | 2.39124553 |
15 | MP0005083_abnormal_biliary_tract | 2.30930473 |
16 | MP0003646_muscle_fatigue | 2.21001541 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.18055583 |
18 | * MP0002118_abnormal_lipid_homeostasis | 2.18028409 |
19 | MP0005666_abnormal_adipose_tissue | 2.14445306 |
20 | MP0001666_abnormal_nutrient_absorption | 2.11521256 |
21 | MP0006036_abnormal_mitochondrial_physio | 2.02433823 |
22 | * MP0000609_abnormal_liver_physiology | 1.96267201 |
23 | MP0009785_altered_susceptibility_to | 1.95135373 |
24 | MP0005319_abnormal_enzyme/_coenzyme | 1.84980270 |
25 | MP0004019_abnormal_vitamin_homeostasis | 1.81753914 |
26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.71725820 |
27 | MP0002971_abnormal_brown_adipose | 1.71614516 |
28 | MP0005330_cardiomyopathy | 1.64351655 |
29 | MP0003186_abnormal_redox_activity | 1.63227579 |
30 | MP0002138_abnormal_hepatobiliary_system | 1.59183469 |
31 | MP0004145_abnormal_muscle_electrophysio | 1.53709840 |
32 | MP0004185_abnormal_adipocyte_glucose | 1.51837457 |
33 | MP0001835_abnormal_antigen_presentation | 1.50258405 |
34 | MP0009643_abnormal_urine_homeostasis | 1.49423594 |
35 | MP0005408_hypopigmentation | 1.46650832 |
36 | MP0002132_abnormal_respiratory_system | 1.46503505 |
37 | MP0001764_abnormal_homeostasis | 1.45454333 |
38 | MP0005451_abnormal_body_composition | 1.38303827 |
39 | MP0004084_abnormal_cardiac_muscle | 1.37302949 |
40 | MP0009697_abnormal_copulation | 1.30692171 |
41 | MP0004215_abnormal_myocardial_fiber | 1.28305944 |
42 | MP0003705_abnormal_hypodermis_morpholog | 1.24624087 |
43 | MP0003868_abnormal_feces_composition | 1.24392744 |
44 | MP0005375_adipose_tissue_phenotype | 1.23757908 |
45 | MP0005671_abnormal_response_to | 1.21993353 |
46 | MP0004036_abnormal_muscle_relaxation | 1.21613196 |
47 | MP0008775_abnormal_heart_ventricle | 1.18767725 |
48 | MP0002148_abnormal_hypersensitivity_rea | 1.18261691 |
49 | MP0006082_CNS_inflammation | 1.16140863 |
50 | * MP0005535_abnormal_body_temperature | 1.13505925 |
51 | MP0000751_myopathy | 1.12105776 |
52 | MP0006035_abnormal_mitochondrial_morpho | 1.12093751 |
53 | MP0010368_abnormal_lymphatic_system | 1.10488404 |
54 | MP0005334_abnormal_fat_pad | 1.09032694 |
55 | MP0000372_irregular_coat_pigmentation | 1.08649051 |
56 | MP0005025_abnormal_response_to | 1.07722213 |
57 | MP0000749_muscle_degeneration | 1.07086843 |
58 | MP0003011_delayed_dark_adaptation | 1.06701326 |
59 | * MP0002078_abnormal_glucose_homeostasis | 1.06625125 |
60 | MP0005464_abnormal_platelet_physiology | 1.02236639 |
61 | MP0002419_abnormal_innate_immunity | 1.02050017 |
62 | MP0004087_abnormal_muscle_fiber | 1.01834547 |
63 | MP0001544_abnormal_cardiovascular_syste | 1.00398687 |
64 | MP0005385_cardiovascular_system_phenoty | 1.00398687 |
65 | * MP0000598_abnormal_liver_morphology | 0.99937506 |
66 | MP0001845_abnormal_inflammatory_respons | 0.98837786 |
67 | MP0002166_altered_tumor_susceptibility | 0.96988410 |
68 | MP0003656_abnormal_erythrocyte_physiolo | 0.96939937 |
69 | MP0004043_abnormal_pH_regulation | 0.96704189 |
70 | MP0002972_abnormal_cardiac_muscle | 0.96455735 |
71 | MP0005166_decreased_susceptibility_to | 0.94437022 |
72 | MP0003828_pulmonary_edema | 0.93913404 |
73 | MP0006138_congestive_heart_failure | 0.93590074 |
74 | MP0001790_abnormal_immune_system | 0.91996355 |
75 | MP0005387_immune_system_phenotype | 0.91996355 |
76 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91738057 |
77 | MP0009763_increased_sensitivity_to | 0.91197225 |
78 | MP0001800_abnormal_humoral_immune | 0.89930384 |
79 | MP0005266_abnormal_metabolism | 0.89743572 |
80 | MP0003075_altered_response_to | 0.89460276 |
81 | MP0001661_extended_life_span | 0.88333130 |
82 | MP0009115_abnormal_fat_cell | 0.88251977 |
83 | MP0005636_abnormal_mineral_homeostasis | 0.88213512 |
84 | MP0002127_abnormal_cardiovascular_syste | 0.87931195 |
85 | MP0005620_abnormal_muscle_contractility | 0.87886251 |
86 | MP0002269_muscular_atrophy | 0.87240268 |
87 | MP0001756_abnormal_urination | 0.86276921 |
88 | MP0010630_abnormal_cardiac_muscle | 0.86107927 |
89 | MP0000685_abnormal_immune_system | 0.85981880 |
90 | MP0005000_abnormal_immune_tolerance | 0.83806866 |
91 | MP0009764_decreased_sensitivity_to | 0.83629058 |
92 | MP0005084_abnormal_gallbladder_morpholo | 0.83267642 |
93 | * MP0009642_abnormal_blood_homeostasis | 0.82590387 |
94 | MP0010155_abnormal_intestine_physiology | 0.80890117 |
95 | MP0005647_abnormal_sex_gland | 0.80781628 |
96 | MP0005379_endocrine/exocrine_gland_phen | 0.80767556 |
97 | MP0002970_abnormal_white_adipose | 0.80634228 |
98 | MP0005376_homeostasis/metabolism_phenot | 0.80129245 |
99 | MP0002876_abnormal_thyroid_physiology | 0.78957567 |
100 | MP0008438_abnormal_cutaneous_collagen | 0.78837907 |
101 | MP0003183_abnormal_peptide_metabolism | 0.78648384 |
102 | MP0000230_abnormal_systemic_arterial | 0.77667827 |
103 | MP0004147_increased_porphyrin_level | 0.77559359 |
104 | MP0005448_abnormal_energy_balance | 0.75924489 |
105 | MP0008469_abnormal_protein_level | 0.74953521 |
106 | MP0004883_abnormal_blood_vessel | 0.74796069 |
107 | MP0005058_abnormal_lysosome_morphology | 0.74512941 |
108 | MP0002723_abnormal_immune_serum | 0.74436815 |
109 | MP0005164_abnormal_response_to | 0.73847382 |
110 | MP0002332_abnormal_exercise_endurance | 0.73829821 |
111 | MP0002452_abnormal_antigen_presenting | 0.73083955 |
112 | MP0003950_abnormal_plasma_membrane | 0.71443895 |
113 | MP0003724_increased_susceptibility_to | 0.69073188 |
114 | MP0002254_reproductive_system_inflammat | 0.66623140 |
115 | MP0003137_abnormal_impulse_conducting | 0.61309285 |
116 | MP0000747_muscle_weakness | 0.59338325 |
117 | MP0002136_abnormal_kidney_physiology | 0.59047241 |
118 | MP0000343_altered_response_to | 0.59018897 |
119 | MP0003690_abnormal_glial_cell | 0.58006136 |
120 | MP0004484_altered_response_of | 0.57960197 |
121 | MP0000750_abnormal_muscle_regeneration | 0.57338105 |
122 | MP0000003_abnormal_adipose_tissue | 0.56230351 |
123 | MP0003959_abnormal_lean_body | 0.55717005 |
124 | MP0000013_abnormal_adipose_tissue | 0.53645562 |
125 | MP0005165_increased_susceptibility_to | 0.52467846 |
126 | MP0003953_abnormal_hormone_level | 0.51256182 |
127 | MP0000604_amyloidosis | 0.51237045 |
128 | MP0000759_abnormal_skeletal_muscle | 0.50226788 |
129 | MP0001853_heart_inflammation | 0.49778973 |
130 | MP0002106_abnormal_muscle_physiology | 0.48668407 |
131 | MP0001879_abnormal_lymphatic_vessel | 0.46805592 |
132 | MP0009765_abnormal_xenobiotic_induced | 0.46379147 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.22771281 |
2 | Hypoglycemic coma (HP:0001325) | 5.19977076 |
3 | Hyperglycinuria (HP:0003108) | 5.07352727 |
4 | Intrahepatic cholestasis (HP:0001406) | 5.01371099 |
5 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.93042680 |
6 | Xanthomatosis (HP:0000991) | 4.92032019 |
7 | Hyperammonemia (HP:0001987) | 4.88643904 |
8 | Deep venous thrombosis (HP:0002625) | 4.81038730 |
9 | Ketosis (HP:0001946) | 4.66696535 |
10 | Abnormality of glycine metabolism (HP:0010895) | 4.64504659 |
11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.64504659 |
12 | Hyperlipoproteinemia (HP:0010980) | 4.32331775 |
13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.29148046 |
14 | Hyperglycinemia (HP:0002154) | 4.28884051 |
15 | Hypobetalipoproteinemia (HP:0003563) | 4.27462565 |
16 | Dicarboxylic aciduria (HP:0003215) | 4.18096152 |
17 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.18096152 |
18 | Ketoacidosis (HP:0001993) | 4.15287883 |
19 | Prolonged partial thromboplastin time (HP:0003645) | 4.08501064 |
20 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.06403129 |
21 | Hypoalphalipoproteinemia (HP:0003233) | 3.88189329 |
22 | Hypolipoproteinemia (HP:0010981) | 3.84202845 |
23 | Myoglobinuria (HP:0002913) | 3.83151690 |
24 | Generalized aminoaciduria (HP:0002909) | 3.79360896 |
25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.67220655 |
26 | Epidermoid cyst (HP:0200040) | 3.65563839 |
27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.64942984 |
28 | Mitochondrial inheritance (HP:0001427) | 3.64649002 |
29 | Complement deficiency (HP:0004431) | 3.64018457 |
30 | Cerebral edema (HP:0002181) | 3.54358082 |
31 | Systemic lupus erythematosus (HP:0002725) | 3.52719369 |
32 | Progressive macrocephaly (HP:0004481) | 3.52460280 |
33 | Hepatic necrosis (HP:0002605) | 3.29763296 |
34 | Metabolic acidosis (HP:0001942) | 3.24575410 |
35 | Rhabdomyolysis (HP:0003201) | 3.21952506 |
36 | Lethargy (HP:0001254) | 3.21709676 |
37 | Proximal tubulopathy (HP:0000114) | 3.08207255 |
38 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.04016578 |
39 | Nausea (HP:0002018) | 3.02471923 |
40 | * Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.02219272 |
41 | Abnormality of methionine metabolism (HP:0010901) | 3.00315666 |
42 | Joint hemorrhage (HP:0005261) | 2.96485939 |
43 | Abnormality of the common coagulation pathway (HP:0010990) | 2.93605439 |
44 | Renal cortical cysts (HP:0000803) | 2.90374142 |
45 | * Abnormality of serum amino acid levels (HP:0003112) | 2.89983582 |
46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.80646315 |
47 | Acute encephalopathy (HP:0006846) | 2.78566268 |
48 | Hypercholesterolemia (HP:0003124) | 2.77239189 |
49 | Fat malabsorption (HP:0002630) | 2.73636063 |
50 | Vomiting (HP:0002013) | 2.72130175 |
51 | Abnormality of purine metabolism (HP:0004352) | 2.71381078 |
52 | Increased muscle lipid content (HP:0009058) | 2.69792961 |
53 | Delayed CNS myelination (HP:0002188) | 2.68353915 |
54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.63806513 |
55 | Hyperbilirubinemia (HP:0002904) | 2.62608230 |
56 | Skin nodule (HP:0200036) | 2.62250078 |
57 | Abnormality of nucleobase metabolism (HP:0010932) | 2.53733599 |
58 | Abnormality of complement system (HP:0005339) | 2.53383781 |
59 | Renal Fanconi syndrome (HP:0001994) | 2.48473475 |
60 | Gout (HP:0001997) | 2.48009636 |
61 | Abnormality of proline metabolism (HP:0010907) | 2.47772994 |
62 | Hydroxyprolinuria (HP:0003080) | 2.47772994 |
63 | Reduced antithrombin III activity (HP:0001976) | 2.45720991 |
64 | Abnormality of urine glucose concentration (HP:0011016) | 2.43032816 |
65 | Glycosuria (HP:0003076) | 2.43032816 |
66 | Glomerulonephritis (HP:0000099) | 2.41245749 |
67 | Exercise-induced myalgia (HP:0003738) | 2.39739525 |
68 | Respiratory failure (HP:0002878) | 2.39479046 |
69 | Abnormality of glycolysis (HP:0004366) | 2.38433197 |
70 | Increased serum pyruvate (HP:0003542) | 2.38433197 |
71 | Hypoglycemic seizures (HP:0002173) | 2.38327587 |
72 | Palpitations (HP:0001962) | 2.38029331 |
73 | Hyperphosphaturia (HP:0003109) | 2.37982872 |
74 | Lipid accumulation in hepatocytes (HP:0006561) | 2.37082466 |
75 | Increased hepatocellular lipid droplets (HP:0006565) | 2.34393381 |
76 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.34153171 |
77 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.34153171 |
78 | Dilated cardiomyopathy (HP:0001644) | 2.32033018 |
79 | Lactic acidosis (HP:0003128) | 2.27087670 |
80 | Conjugated hyperbilirubinemia (HP:0002908) | 2.26961611 |
81 | Hepatocellular necrosis (HP:0001404) | 2.24994430 |
82 | Cerebral palsy (HP:0100021) | 2.24440892 |
83 | Myocardial infarction (HP:0001658) | 2.23864223 |
84 | 3-Methylglutaconic aciduria (HP:0003535) | 2.23211167 |
85 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.23095596 |
86 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.21944599 |
87 | Hyperuricemia (HP:0002149) | 2.21493901 |
88 | Increased purine levels (HP:0004368) | 2.21493901 |
89 | Hypertriglyceridemia (HP:0002155) | 2.21300561 |
90 | Bundle branch block (HP:0011710) | 2.20017067 |
91 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.18438641 |
92 | Hepatocellular carcinoma (HP:0001402) | 2.18150107 |
93 | Exercise intolerance (HP:0003546) | 2.16843962 |
94 | Pancreatitis (HP:0001733) | 2.16724793 |
95 | Abnormal cartilage morphology (HP:0002763) | 2.15129172 |
96 | Methylmalonic aciduria (HP:0012120) | 2.14641308 |
97 | Right ventricular cardiomyopathy (HP:0011663) | 2.14532777 |
98 | Cholelithiasis (HP:0001081) | 2.13754973 |
99 | CNS demyelination (HP:0007305) | 2.11520199 |
100 | Abnormal gallbladder morphology (HP:0012437) | 2.09797671 |
101 | Acute necrotizing encephalopathy (HP:0006965) | 2.09585775 |
102 | Sudden death (HP:0001699) | 2.08669802 |
103 | Conjunctival hamartoma (HP:0100780) | 2.05024612 |
104 | Hyperglycemia (HP:0003074) | 2.04346922 |
105 | Ragged-red muscle fibers (HP:0003200) | 2.03020622 |
106 | Ventricular tachycardia (HP:0004756) | 2.02522051 |
107 | Late onset (HP:0003584) | 2.00547479 |
108 | Steatorrhea (HP:0002570) | 1.99018336 |
109 | Exertional dyspnea (HP:0002875) | 1.98414103 |
110 | Asymmetric septal hypertrophy (HP:0001670) | 1.95443562 |
111 | Exercise-induced muscle cramps (HP:0003710) | 1.95427189 |
112 | Increased serum lactate (HP:0002151) | 1.91821683 |
113 | Syncope (HP:0001279) | 1.91125432 |
114 | Type I transferrin isoform profile (HP:0003642) | 1.90581900 |
115 | Increased intramyocellular lipid droplets (HP:0012240) | 1.90100137 |
116 | Sensorimotor neuropathy (HP:0007141) | 1.89715349 |
117 | Nemaline bodies (HP:0003798) | 1.89573395 |
118 | Brushfield spots (HP:0001088) | 1.89065052 |
119 | Vascular calcification (HP:0004934) | 1.88581871 |
120 | Gingival bleeding (HP:0000225) | 1.88150813 |
121 | Muscle fiber inclusion bodies (HP:0100299) | 1.87720949 |
122 | Increased CSF lactate (HP:0002490) | 1.87582508 |
123 | Oligomenorrhea (HP:0000876) | 1.85845034 |
124 | Lipoatrophy (HP:0100578) | 1.85774438 |
125 | Elevated hepatic transaminases (HP:0002910) | 1.85364580 |
126 | Neonatal onset (HP:0003623) | 1.84959290 |
127 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.84766085 |
128 | Abnormality of renal resorption (HP:0011038) | 1.84638644 |
129 | Respiratory distress (HP:0002098) | 1.84383955 |
130 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.83849509 |
131 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.80622542 |
132 | Optic disc pallor (HP:0000543) | 1.79273345 |
133 | Hyporeflexia of lower limbs (HP:0002600) | 1.78500858 |
134 | Ventricular arrhythmia (HP:0004308) | 1.77681745 |
135 | Heart block (HP:0012722) | 1.77565425 |
136 | Spontaneous abortion (HP:0005268) | 1.74532499 |
137 | Abnormal urine phosphate concentration (HP:0012599) | 1.74132733 |
138 | Leukodystrophy (HP:0002415) | 1.73286182 |
139 | Calf muscle hypertrophy (HP:0008981) | 1.72933094 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.10687692 |
2 | PDK3 | 3.61326998 |
3 | PDK4 | 3.61326998 |
4 | TRIB3 | 3.42167649 |
5 | SIK1 | 3.10343409 |
6 | MAP3K12 | 3.04265842 |
7 | PKN2 | 2.77868004 |
8 | TTN | 2.47723425 |
9 | ERN1 | 2.43482212 |
10 | FGFR4 | 2.38122376 |
11 | PDK2 | 2.30468642 |
12 | INSRR | 2.23384716 |
13 | OBSCN | 2.13210409 |
14 | EIF2AK3 | 2.07893032 |
15 | TIE1 | 2.03704575 |
16 | MAP4K2 | 2.03519764 |
17 | LMTK2 | 1.86247391 |
18 | MYLK | 1.85109565 |
19 | EIF2AK1 | 1.83308442 |
20 | PINK1 | 1.81154343 |
21 | FLT3 | 1.80024945 |
22 | NEK9 | 1.78843108 |
23 | MST4 | 1.75076849 |
24 | STK16 | 1.69696733 |
25 | NME2 | 1.59783746 |
26 | PRKAA2 | 1.58168904 |
27 | TXK | 1.55229118 |
28 | CAMK1D | 1.54732633 |
29 | STK38L | 1.54446796 |
30 | RIPK4 | 1.53032849 |
31 | MST1R | 1.46640541 |
32 | ERBB3 | 1.46274729 |
33 | MAP2K3 | 1.46169744 |
34 | PHKG2 | 1.44716346 |
35 | PHKG1 | 1.44716346 |
36 | LATS1 | 1.44490445 |
37 | PIK3CG | 1.43667996 |
38 | PIK3CA | 1.35015709 |
39 | BMPR2 | 1.32344556 |
40 | SCYL2 | 1.30920462 |
41 | TGFBR2 | 1.26836815 |
42 | MAPK11 | 1.21570264 |
43 | ACVR1B | 1.21292763 |
44 | BLK | 1.20603875 |
45 | KDR | 1.19432389 |
46 | NEK1 | 1.17798041 |
47 | LIMK1 | 1.17651788 |
48 | BMPR1B | 1.14013709 |
49 | DMPK | 1.13670480 |
50 | JAK3 | 1.13566604 |
51 | CSK | 1.12138520 |
52 | ITK | 1.08834941 |
53 | DAPK3 | 1.08678645 |
54 | MAP3K7 | 1.08164347 |
55 | WNK4 | 1.06956566 |
56 | PIM2 | 1.06432140 |
57 | TESK1 | 1.06403250 |
58 | TAOK3 | 1.05210739 |
59 | SYK | 1.04962832 |
60 | TRPM7 | 1.04795381 |
61 | FRK | 1.04215189 |
62 | MAP3K3 | 0.98071471 |
63 | BTK | 0.97271855 |
64 | ROCK1 | 0.95224134 |
65 | ADRBK2 | 0.93805058 |
66 | IKBKE | 0.93404114 |
67 | PRKAA1 | 0.93024652 |
68 | MAP2K4 | 0.92142700 |
69 | ERBB4 | 0.90932178 |
70 | PTK6 | 0.90476785 |
71 | RIPK1 | 0.90142939 |
72 | MAPK12 | 0.90075437 |
73 | TYK2 | 0.89044129 |
74 | ARAF | 0.85166707 |
75 | TNK2 | 0.83456533 |
76 | ABL2 | 0.81966555 |
77 | LYN | 0.80495832 |
78 | STK24 | 0.80417052 |
79 | PRKCQ | 0.79767953 |
80 | PRKCE | 0.79655402 |
81 | ZAP70 | 0.79517340 |
82 | GRK1 | 0.76805369 |
83 | JAK1 | 0.74723205 |
84 | OXSR1 | 0.74709480 |
85 | IRAK3 | 0.73295183 |
86 | MAP4K1 | 0.72787125 |
87 | JAK2 | 0.72574212 |
88 | CAMKK2 | 0.72228833 |
89 | TBK1 | 0.71429968 |
90 | PRKACG | 0.69128479 |
91 | NUAK1 | 0.68045952 |
92 | IKBKB | 0.66802566 |
93 | PDPK1 | 0.66404615 |
94 | CAMK1G | 0.65582177 |
95 | MATK | 0.64628999 |
96 | FER | 0.62613865 |
97 | NLK | 0.60892486 |
98 | FGFR2 | 0.60665752 |
99 | LCK | 0.60222474 |
100 | PRKG1 | 0.58951893 |
101 | MAP3K11 | 0.58512088 |
102 | PRKD1 | 0.58511850 |
103 | MAPK4 | 0.58167315 |
104 | VRK2 | 0.55395339 |
105 | EPHB1 | 0.54986690 |
106 | EPHB2 | 0.53792425 |
107 | MAP2K1 | 0.53218490 |
108 | STK4 | 0.52900777 |
109 | MAP2K6 | 0.52864701 |
110 | PDK1 | 0.51804157 |
111 | VRK1 | 0.50830268 |
112 | MAP3K5 | 0.50433987 |
113 | ADRBK1 | 0.49989906 |
114 | GSK3A | 0.49522274 |
115 | MAPK7 | 0.49368318 |
116 | MET | 0.49081380 |
117 | MAPKAPK3 | 0.48712101 |
118 | IRAK4 | 0.48370606 |
119 | PDGFRA | 0.47606846 |
120 | CAMK4 | 0.47009551 |
121 | CAMK2G | 0.46904443 |
122 | GRK7 | 0.46115427 |
123 | PRKG2 | 0.45891400 |
124 | FGFR3 | 0.45659099 |
125 | MUSK | 0.44800269 |
126 | PAK3 | 0.44368221 |
127 | CDK6 | 0.42981105 |
128 | SGK3 | 0.42042298 |
129 | ILK | 0.40081864 |
130 | CDK4 | 0.39172724 |
131 | LRRK2 | 0.36203418 |
132 | IGF1R | 0.34726921 |
133 | STK3 | 0.31305927 |
134 | AKT2 | 0.29201855 |
135 | TGFBR1 | 0.27626691 |
136 | STK39 | 0.27439245 |
137 | PRKCZ | 0.27178347 |
138 | PRKACA | 0.27022761 |
139 | ERBB2 | 0.25394393 |
140 | TAOK2 | 0.25280591 |
141 | KIT | 0.24118589 |
142 | RET | 0.24031046 |
143 | EPHA3 | 0.23953883 |
144 | SGK2 | 0.23740806 |
145 | CSF1R | 0.23425723 |
146 | PRKACB | 0.23094685 |
147 | WNK3 | 0.22286293 |
148 | CAMK2D | 0.22245190 |
149 | DYRK1B | 0.22066092 |
150 | MTOR | 0.22040765 |
151 | TEC | 0.21390969 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.43490902 |
2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.38508765 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.33237309 |
4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.29901256 |
5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.94751584 |
6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.82674592 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.79825258 |
8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.73070532 |
9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.72058228 |
10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.68575002 |
11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.62204558 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57202652 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51406831 |
14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.44180918 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.42260659 |
16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.35669199 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.19220886 |
18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.02253997 |
19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.02224804 |
20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.95182637 |
21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.92796573 |
22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.90061359 |
23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.88958726 |
24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.84527908 |
25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.84183891 |
26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.64295879 |
27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51499724 |
28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47498021 |
29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46370453 |
30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45022867 |
31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44962543 |
32 | Proteasome_Homo sapiens_hsa03050 | 1.39365541 |
33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.37403401 |
34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34404583 |
35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34291823 |
36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.33539247 |
37 | Asthma_Homo sapiens_hsa05310 | 1.33298365 |
38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29791853 |
39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27324744 |
40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26683801 |
41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25959319 |
42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24048956 |
43 | Protein export_Homo sapiens_hsa03060 | 1.22437318 |
44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19207939 |
45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18657871 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18222726 |
47 | Bile secretion_Homo sapiens_hsa04976 | 1.17133684 |
48 | Allograft rejection_Homo sapiens_hsa05330 | 1.14755726 |
49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08135883 |
50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06146779 |
51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04431292 |
52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.04166527 |
53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04126592 |
54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03401393 |
55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00333723 |
56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95676742 |
57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95031180 |
58 | ABC transporters_Homo sapiens_hsa02010 | 0.93503164 |
59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92886607 |
60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91242928 |
61 | Lysine degradation_Homo sapiens_hsa00310 | 0.89385607 |
62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89368355 |
63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88553182 |
64 | Ribosome_Homo sapiens_hsa03010 | 0.85373260 |
65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81904955 |
66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80711012 |
67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80036366 |
68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73064712 |
69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71954039 |
70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.70693345 |
71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70681702 |
72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70657763 |
73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68016194 |
74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65596025 |
75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64215720 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61449888 |
77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59897897 |
78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56743205 |
79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54797487 |
80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53526301 |
81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51526686 |
82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51514362 |
83 | Insulin resistance_Homo sapiens_hsa04931 | 0.50215974 |
84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.49069160 |
85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47534633 |
86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44790020 |
87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41962257 |
88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41830712 |
89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41711324 |
90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41106825 |
91 | Mineral absorption_Homo sapiens_hsa04978 | 0.40011363 |
92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.36151997 |
93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35700074 |
94 | Pertussis_Homo sapiens_hsa05133 | 0.34435855 |
95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34388451 |
96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34122224 |
97 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33972144 |
98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33538065 |
99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31741931 |
100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28607742 |
101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26348890 |
102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25857573 |
103 | Malaria_Homo sapiens_hsa05144 | 0.22086771 |
104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19957586 |
105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18387126 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16597061 |
107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.16463581 |
108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15680970 |
109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12849801 |
110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08453196 |
111 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.04056770 |
112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.01483476 |
113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.00135864 |
114 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.2066704 |
115 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1690689 |
116 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1219472 |
117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.1119435 |
118 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0868337 |
119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0540456 |
120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0506298 |
121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0501725 |
122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0360662 |
123 | Prion diseases_Homo sapiens_hsa05020 | -0.0162423 |
124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0072020 |